47 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Here's Why You Should Buy Align Technology (ALGN) Stock Now https://www.zacks.com/stock/news/2209986/here-s-why-you-should-buy-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2209986 Jan 15, 2024 - Investors remain optimistic about Align Technology (ALGN) due to the progress in the Invisalign portfolio and highly favorable solvency.
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics https://www.zacks.com/stock/news/2209990/quest-diagnostics-dgx-inks-new-deal-with-ultima-genomics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209990 Jan 15, 2024 - Quest Diagnostics' (DGX) new partnership is likely to leverage its oncology expertise and national scale.
Abbott's (ABT) Innovations Aid, Macroeconomic Issues Stay https://www.zacks.com/stock/news/2211543/abbott-s-abt-innovations-aid-macroeconomic-issues-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2211543 Jan 17, 2024 - Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer.
Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes https://www.zacks.com/stock/news/2212281/penumbra-pen-rides-on-vascular-arm-strength-amid-fx-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2212281 Jan 18, 2024 - Penumbra's (PEN) Vascular business is demonstrating strong growth, banking on a rapid increase in sales of vascular thrombectomy products in the United States.
HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue? https://www.zacks.com/stock/news/2216440/healthequity-inc-hqy-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2216440 Jan 26, 2024 - HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth https://www.zacks.com/stock/news/2239310/healthequity-hqy-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2239310 Mar 12, 2024 - HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2243114/compared-to-estimates-healthequity-hqy-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2243114 Mar 19, 2024 - The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pages: 12345

<<<Page 5